Praised for preventing hundreds of thousands of deaths and allowing a return to more normal life, Covid vaccines will also substantially benefit some pharmaceutical companies. On Thursday Moderna, which received US government funding to develop its vaccine, will reveal how much it made in the second quarter. With fellow US company Pfizer it will take the lion’s share of global Covid vaccine profits. It has postponed its filing for regulatory approval in the US to the second half of the year because, it said, it took time to put together the large datasets required by the US regulator. The EU will not order any more vaccines from AstraZeneca, and disillusionment has set in.

Source: The Guardian July 31, 2021 23:03 UTC